Bone Marrow Mononuclear Cells Transplantation and Training Increased Transplantation of Energy Source Transporters in Chronic Stroke

2021 ◽  
Vol 30 (8) ◽  
pp. 105932
Author(s):  
Yuko Ogawa ◽  
Orie Saino ◽  
Yuka Okinaka ◽  
Akie Kikuchi-Taura ◽  
Yukiko Takeuchi ◽  
...  
Keyword(s):  
Energy Source ◽  
Bone Marrow ◽  
Mononuclear Cells ◽  
Chronic Stroke ◽  
Bone Marrow Mononuclear Cells ◽  
And Training

scholarly journals Early Tissue Distribution of Bone Marrow Mononuclear Cells After Intra-Arterial Delivery in a Patient With Chronic Stroke

Circulation ◽  
2009 ◽  
Vol 120 (6) ◽  
pp. 539-541 ◽  
Author(s):  
Lea Mirian Barbosa da Fonseca ◽  
Valeria Battistella ◽  
Gabriel Rodriguez de Freitas ◽  
Bianca Gutfilen ◽  
Regina Coeli dos Santos Goldenberg ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Tissue Distribution ◽  
Mononuclear Cells ◽  
Chronic Stroke ◽  
Bone Marrow Mononuclear Cells

scholarly journals Intravenous Bone Marrow Mononuclear Cells Transplantation Improves the Effect of Training in Chronic Stroke Mice

2020 ◽  
Vol 7 ◽  
Author(s):  
Yuko Ogawa ◽  
Yuka Okinaka ◽  
Yukiko Takeuchi ◽  
Orie Saino ◽  
Akie Kikuchi-Taura ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Cell Therapy ◽  
Mononuclear Cells ◽  
Therapeutic Option ◽  
Artery Occlusion ◽  
Chronic Stroke ◽  
Therapeutic Effects ◽  
Bone Marrow Mononuclear Cells ◽  
Stroke Treatment ◽  
Cerebral Artery Occlusion

There is no effective treatment for chronic stroke if the acute or subacute phase is missed. Rehabilitation alone cannot easily achieve a dramatic recovery in function. In contrast to significant therapeutic effects of bone marrow mononuclear cells (BM-MNC) transplantation for acute stroke, mild and non-significant effects have been shown for chronic stroke. In this study, we have evaluated the effect of a combination of BM-MNC transplantation and neurological function training in chronic stroke. The effect of BM-MNC on neurological functional was tested four weeks after permanent middle cerebral artery occlusion (MCAO) insult in mice. BM-MNC (1 × 105cells in 100 μl PBS) were injected into the vein of MCAO model mice, followed by behavioral tests as functional evaluations. Interestingly, there was a significant therapeutic effect of BM-MNC only when repeated training was performed. This suggested that cell therapy alone was not sufficient for chronic stroke treatment; however, training with cell therapy was effective. The combination of these differently targeted therapies provided a significant benefit in the chronic stroke mouse model. Therefore, targeted cell therapy via BM-MNC transplantation with appropriate training presents a promising novel therapeutic option for patients in the chronic stroke period.

scholarly journals Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Alok Sharma ◽  
Hemangi Sane ◽  
Nandini Gokulchandran ◽  
Dipti Khopkar ◽  
Amruta Paranjape ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Cell Therapy ◽  
Mononuclear Cells ◽  
Autologous Bone Marrow ◽  
Chronic Stroke ◽  
Bone Marrow Mononuclear Cells ◽  
Hand Functions ◽  
Intrathecal Transplantation ◽  
Autologous Bone ◽  
Walking Balance

Cell therapy is being widely explored in the management of stroke and has demonstrated great potential. It has been shown to assist in the remodeling of the central nervous system by inducing neurorestorative effect through the process of angiogenesis, neurogenesis, and reduction of glial scar formation. In this study, the effect of intrathecal administration of autologous bone marrow mononuclear cells (BMMNCs) is analyzed on the recovery process of patients with chronic stroke. 24 patients diagnosed with chronic stroke were administered cell therapy, followed by multidisciplinary neurorehabilitation. They were assessed on functional independence measure (FIM) objectively, along with assessment of standing and walking balance, ambulation, and hand functions. Out of 24 patients, 12 improved in ambulation, 10 in hand functions, 6 in standing balance, and 9 in walking balance. Further factor analysis was done. Patients of the younger groups showed higher percentage of improvement in all the areas. Patients who underwent cell therapy within 2 years after the stroke showed better changes. Ischemic type of stroke had better recovery than the hemorrhagic stroke. This study demonstrates the potential of autologous BMMNCs intrathecal transplantation in improving the prognosis of functional recovery in chronic stage of stroke. Further clinical trials are recommended. This trial is registered withNCT02065778.

scholarly journals Corrigendum to “Characterization of Bone Marrow Mononuclear Cells on Biomaterials for Bone Tissue EngineeringIn Vitro”

2015 ◽  
Vol 2015 ◽  
pp. 1-1
Author(s):  
Dirk Henrich ◽  
René Verboket ◽  
Alexander Schaible ◽  
Kerstin Kontradowitz ◽  
Elsie Oppermann ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Bone Tissue ◽  
Mononuclear Cells ◽  
Bone Marrow Mononuclear Cells
Sign in / Sign up

Export Citation Format

Share Document